CDK11B and hepatocellular carcinoma: To further validate that USP22 increases hepatocellular carcinoma cell proliferation by stabilising CDK11B protein, we overexpressed His‐CDK11B in USP22 knockout cells (Figure 4F) and evaluated cell proliferation.